bpc 157 banned in sports BPC-157 by US Regulators | Sarav Shah, MD, FAAOS posted on the topic BPC-157: Experimental Peptide Creates Risk

R., Colucci, L

Its immune-modulating properties have attracted considerable interest among clinicians seeking supportive therapies for individuals with recurrent infections or impaired immune function

It helps reduce oxidative stress, promote tissue repair, and boost recovery after training or daily challenges

Reducing the risk of metabolic diseases: Inhibiting NNMT may counteract the adverse metabolic changes associated with obesity, such as fatty liver disease

These include, extreme tiredness, a lack of energy, pins and needles, muscle weakness, disturbed vision, mouth ulcers, a sore and red tongue, and cognitive or psychological concerns such as depression, confusion, and difficulty with memory, understanding or judgement